Real-world baseline characteristics and diagnostic path of Polish patients with ALK-positive NSCLC eligible for brigatinib treatment: Interim results from the ENTIRETY study. This is an ASCO Meeting ...

Artificial intelligence and predictive analytics are advancing diabetes prevention, diagnosis, and management by integrating data from continuous glucose monitors, electronic health records, and other ...

PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated flagship live cell ChemoFx® ...

Molecular profiling is poised to refine lupus nephritis classification and guide individualized management strategies. Early reductions in serum syndecan-1 and vascular cell adhesion molecule 1 ...